Revenue: The sum of all revenue fields included for a company's operating activities.
Sangamo Therapeutics, Inc. (SGMO) had Revenue of $57.80M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$57.80M |
$-97.94M |
|
-- |
|
$57.80M |
|
$161.77M |
|
$-103.97M |
|
$5.86M |
|
$-98.11M |
|
$-98.11M |
|
$-97.94M |
|
$-97.94M |
|
$-97.94M |
|
$-97.94M |
|
$-103.97M |
|
$-94.88M |
|
201.70M |
|
201.70M |
|
$-0.49 |
|
$-0.49 |
|
| Balance Sheet Financials | |
$51.69M |
|
$17.89M |
|
$49.94M |
|
$101.64M |
|
$45.80M |
|
-- |
|
$33.06M |
|
$78.86M |
|
$22.77M |
|
$22.77M |
|
$22.77M |
|
212.84M |
|
| Cash Flow Statement Financials | |
$-67.14M |
|
$37.52M |
|
$28.38M |
|
$46.70M |
|
$43.42M |
|
$-3.29M |
|
$12.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.13 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-179.88% |
|
-179.88% |
|
-164.15% |
|
-169.74% |
|
-169.45% |
|
$-67.41M |
|
-- |
|
-- |
|
-- |
|
0.57 |
|
-- |
|
109.89 |
|
3.32 |
|
-430.13% |
|
-430.13% |
|
-96.37% |
|
-430.13% |
|
$0.11 |
|
$-0.33 |
|
$-0.33 |
|